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ABSTRACT 
Purpose:  Lower  extremity  amputation  prevention  (LEAP)  is  an  ongoing  program  in  our  institution  aimed  at 
salvaging  limbs  in  patients  with  critical  limb  ischemia  (CLI).  Patients  in  the  LEAP  program  with  reconstructible 
anatomy on initial Doppler imaging received either bypass surgery or percutaneous transluminal balloon angioplasty 
(PTA). We present the 3 year limb salvage rate and angiographic disease patterns in 42 consecutive diabetic patients 
with CLI who received PTA in 2005. 
Methods and Material: 26 women and 16 men with diabetes between the ages of 45 and 91 years old (mean age, 
70.8 years) received PTA in 2005. Presenting symptoms were rest pain (n = 22), pre existing gangrene (n = 17), non 
healing ulcer (n = 16) and cellulitis (n = 2). The aim of the PTA was to achieve straight line flow from the abdominal 
aorta down to the patent dorsalis pedis or plantar arch, with limb salvage as the ultimate outcome. Failure of treatment 
was defined as any amputation above the level of a Syme’s amputation or the need for further surgical bypass. Technical 
success was achieved in 90% (38 out of 42 patients). 
Results: Limb salvage rates were 93% at 1 month, 87% at 3 months, 82% at 6 months, 78% at 1 year, 69% at 2 
years and 66% at 3 years. Mortality was 17% (n = 7) at 3 years. Of the 13 patients with failed therapy, 3 underwent 
bypass, 9 had amputations and 1 had bypass followed by amputation. Four of the cases required further intervention due 
to worsening gangrene and infection, while the remaining was due to persistent rest pain. The rest of the 32 patients had 
no lower limb related issues at the end of 3 years, with improvement of the presenting symptoms. Patterns of treated 
segments were aortoiliac occlusions (n = 3), pure infrapopliteal disease (n = 3), femoropopliteal with at least 1 good 
infrapopliteal run off vessel (n = 14) and combined femoropopliteal and infrapopliteal disease (n = 25).  
Conclusion: Involvement of infrapopliteal vessels that needs to be treated is common in Asian diabetics. While 
early limb salvage rates up to 1 year are similar, the 3 year limb salvage rates in Asian diabetics are lower than the 
western population. © 2010 Biomedical Imaging and Intervention Journal. All rights reserved. 
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INTRODUCTION 
Diabetes  mellitus  (DM)  is  a  multisystem  disorder 
often  associated  with  peripheral  vascular  disease.  The 
disease is a common cause of small vessel vasculopathy, 
hence  accounting  for  the  myriad  forms  of  clinical 
presentation.  The  described  pattern  of  atherosclerotic 
disease  is  often  more  diffuse  in  diabetics,  with  more 
severe involvement of the distal small vessels.  
Critical limb ischemia (CLI) is the most severe form 
of peripheral vascular disease where there is inadequate 
blood flow to a limb to maintain reasonable metabolic 
requirement  of  tissues  at  rest.  The  lower  extremity 
amputation  prevention  (LEAP)  is  a  comprehensive 
program aimed at reducing lower extremity amputations 
in individuals with peripheral vascular disease. The aims 
of LEAP are to detect and treat early chronic ischaemic 
lesions,  offer  alternatives  to  amputations  in  surgically 
untreatable  patients,  preserve  the  remaining  limb  after 
major  amputation  and  reduce  the  global  risk  for 
cardiovascular  disease.  Hence,  it  is  a  multidisciplinary 
program  with  involvement  at  various  levels  from  risk 
factor modification and patient education at the primary 
healthcare  level,  to  active  treatment  of  critical  limb 
ischaemia at tertiary institutions.  
Critical  limb  ischaemia  may  be  treated 
conservatively.  However,  if  conservative  therapy  does 
not  lead  to  improvement  (showing  symptoms  like 
increasing  wound  size,  and  persistent  or  spreading 
infection),  intervention  in  the  form  of  percutaneous 
transluminal angioplasty (PTA) or bypass surgery should 
be  done.  It  has  been  described  that  critical  limb 
ischaemia has a three year limb loss rate of 40% [1] with 
conservative therapy. 
There have been few studies describing the pattern 
of lower limb peripheral vascular disease in a diabetic 
population, especially the Asian diabetic population. We 
aim to describe the pattern of the vascular disease in an 
Asian  Diabetic  population,  as  well  as  3  years  limb 
salvage rates in the these patients, treated by PTA, in the 
LEAP program.  
MATERIALS AND METHODS 
Patient Selection 
Since the inception of LEAP in 2001 up to 2005, a 
total of 301 patients with CLI have been enrolled in this 
study.  Patients  presenting  with  CLI  to  the  authors’ 
institution first received Doppler vascular assessment of 
both  lower  limbs  to  assess  the  anatomical 
reconstructibility of the lower limb arteries. Those with 
reconstructible  anatomy  received  either  bypass  surgery 
or  percutaneous  transluminal  angioplasty  (PTA).  The 
patients  with  non reconstructible  anatomy  received 
hyperbaric  oxygen,  lumbar  sympathectomies  or 
pneumatic compression. Patients who were unfit for any 
of the above received primary amputation and were put 
under close surveillance for the remaining limb. 
Percutaneous Transluminal Angioplasty (PTA) Arm 
In 2005, a total of 46 consecutive patients with CLI 
were enrolled into the PTA treatment arm. The period of 
the study was from 1 January 2005 to 1 January 2008, a 
period of three years. All the patients were recruited and 
followed up in the study period. The time of entry into 
the study was taken as the date of the first angioplasty. 
The patients were enrolled in the PTA treatment arm 
based on the following inclusion criteria: 1) patients who 
were medically unfit for bypass surgery; 2) patients who 
were fit for bypass surgery but chose to have PTA; 3) All 
patients must either have patent dorsalis pedis or a patent 
planter arch on the baseline Doppler vascular maps. Of 
the enrolled 46 patients, 42 were diabetic.  
The  aim  of  the  PTA  was  to  achieve  straight line 
flow  from  the  abdominal  aorta  down  to  the  patent 
dorsalis pedis or plantar arch, with limb salvage as the 
ultimate  outcome.  Technical  success  was  defined  as 
achieving  straight line  flow  from  the  aorta  into  any 
intrapopliteal vessel that supplies either a patent dorsalis 
pedis  or  plantar  arch  via  collateral  reconstitution 
(Figure 1). 
Technical  failure  was  defined  as  any  subsequent 
amputations above the level of a Syme amputation or the 
need  for  surgical  bypass.  All  the  patients  who  were 
enrolled into the PTA treatment arm received PTA as the 
only form of treatment (apart from medical therapy for 
risk factor modification).  
All the angioplasties were performed by one of three 
interventional radiologists in the department. Antegrade 
arteriotomy was preferred and performed in all patients 
who had no evidence of aorto iliac disease on Doppler 
arterial map. Vascular access was secured with a 5.5 F 
vascular sheath (Terumo Corporation, Tokyo, Japan) in 
all  cases.  Intra arterial  heparin  3000  IU  was  routinely 
administered via the vascular sheath at the start of the 
procedure and intra arterial glycerin Trinitrate 200 mcg 
was administered before all tibial angioplasties. 0.035″ 
wires (Terumu Corporation, Tokyo, Japan) were used to 
cross  most  femoropopliteal  lesions  while  smaller 
diameter  0.018″  wires  (V 18)  control  wire  (Boston 
Scientific)  was  used  to  cross  infrapopliteal  lesions. 
Balloons used for angioplasties included: 5 × 40 mm and 
5 × 100 mm 5F (Ultrathin, Boston Scientific) for most 
superficial  femoral  artery  lesions;  and  3 × 40  mm  and 
3 × 100 mm 3F microballoons (Savvy, Cordis/Johnson & 
Johnson)  for  most  infrapopliteal  lesions.  The  decision 
about which balloon to use was based on the length of 
the  lesion.  Short  lesions  were  treated  with  the  shorter 
balloon, while the longer lesions were treated with the 
longer balloon. Only one type of balloon was used for 
any particular lesion. Dissections, if any, received first 
line  treatment  with  prolonged  balloon  inflations.  All 
vascular  sheaths  were  removed  two  hours  after 
angioplasty and homeostasis was controlled by manual 
compression for at least ten minutes. Antiplatelet therapy 
was started immediately post PTA using aspirin 100 mg 
or  clopidogrel  bisulfate  75  mg  for  patients  in  whom 
aspirin was contraindicated. Tan et al. Biomed Imaging Interv J 2010; 6(4):e33    3 
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Figure 1 Pre and Post Angioplasty runs in a 70 Year Old Diabetic Male 
Extensive  atherosclerotic  disease  with  irregular  lumen  in  opacified  vessels  seen  in  pre  and  post  –percutaneous 
transluminal angioplasty (PTA) angiograms. Both Figure A and B are below knee angiograms, with the image on the 
left, being the pre angioplasty run and those on the right the post angioplasty run.  In the pre PTA angiogram, there is 
poor infrapopliteal single vessel  (anterior tibial artery) run off into the foot.  Long occlusions of the peroneal and 
posterior tibial arteries are also  present bu not angioplastied. The post PTA angiogram demonstrated technical success 
in achieving “straight line flow” into the dorsalis pedis. 
 
Follow-up 
ABI (Ankle Brachial Index), TP (Toe Pressure) and 
digital brachial  index  (DBI)  measurements  were  also 
obtained  before  angioplasty  and  on  the  first  day  post 
angioplasty. Post procedure surveillance was conducted 
in  the  form  of  three monthly  clinic  reviews  by  the 
referring  vascular  surgeon.  ABI,  as  well  as  relevant 
indicators  of  clinical  improvement  like  wound  healing 
and  rest  pain,  was  evaluated.  The  patients  were  kept 
under  surveillance  for  periods  ranging  from  25  to  35 
months, with a mean of 31.2 months.  
Outcome Assessment 
The  study  describes  the  pattern  of  the  vascular 
disease as well as the three year limb salvage rates in the 
subgroup  of  diabetic  patients,  treated  by  PTA,  in  the 
LEAP program. All the patients were recruited in 2005, 
and followed up to 2008, a total of three years. The one 
month, three month, six month, one year, two year and 
three year limb salvage rates were studied.  
Statistical Analysis 
SPSS  software  was  used  for  statistical  analysis. 
Paired T tests were performed to determine if there was 
any  statistical  difference  in  the  improvement  of  the 
measures  of  haemodynamic  markers  within  the 
technically  successful  group.  Kaplan Meir  analysis  of 
both the limb salvage rate, as well as a combined salvage 
and survival rate was performed. 
RESULTS 
There were 42 patients studied, of which 26 were 
women and 16 were men, between the ages of 45 and 91 
years (mean age, 70.8). The ethnic distribution was 76% 
Chinese,  10%  Malays  and  14%  Indians.  Common 
presenting  symptoms  were  rest  pain  (n = 22),  pre 
existing  gangrene  (n = 17),  non healing  ulcer  (n = 16) 
and cellulitis (n = 2) (Figure 2).  
 
Figure 2  Range of presenting symptoms 
 
A total of 40 femoral, one brachial and one popliteal 
arteriotomy  were  performed  and  the  angiograms 
obtained.  Patterns  of  treated  segments  were  aorto iliac 
occlusions  (n = 3),  pure  infra popliteal  disease  (n = 3), 
femoropopliteal with at least 1 good intrapopliteal run 
off  vessel  (n = 14),  and  combined  femoropopliteal  and 
intrapopliteal disease (n = 25) (Figure 3). A summary of 
the locations of the chronic total occlusions and severe 
stenosis is shown in Table 1.  Tan et al. Biomed Imaging Interv J 2010; 6(4):e33    4 
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Table 1 Summary of locations of the chronic total occlusions and severe stenosis 
 
  Superficial femoral artery  Infrapopliteal 
Chronic total occlusion  N = 15, range  1 to 25 cm, mean 8.13 cm  N = 21, 1 to 23 cm, mean 10.1 cm 
Severe stenosis 
(> 70% stenosis)  N = 26,  range 1 to 30 cm, mean 9.34 cm  N = 23, 2 to 25 cm, mean 8.73 cm 
 
   
 
Figure 3 Patterns of Treated diseases 
 
Technical  success  was  achieved  in  90%  of  the 
patients (38 out of 42 patients). The most common cause 
of technical failure was inability to cross long chronic 
occlusions  (CTOs).  The  locations  of  the  CTOs  in  the 
failed cases were the anterior tibial artery (n = 3; 15, 20 
and 23 cm in lengths) and complete distal posterior tibial 
(n = 1). In all 4 technical failures, subintimal PTA was 
attempted with failed re entry. 
Transluminal  angioplasty  was  performed  in  35 
patients.  Both  transluminal  and  subintimal  angioplasty 
were  performed  in  4  patients.  Three  patients  received 
subintimal  angioplasty.  Only  in  one  case  was  an 
endovascular stent deployed (over an iliac stenosis). In 
the  technically  successful  group,  repeat  interval 
angioplasties were performed on 4 patients at 6 weeks 
(n = 2), four months (n = 1) and seven months (n = 1). 
Paired T tests showed statistical improvement in the 
haemodynamic markers within the technically successful 
group. This included mean ABI improvement from 0.60 
(pre angioplasty)  to  0.91  (day  one  post angioplasty), 
which  was  a  significant  increase  of  0.31  [95% 
confidence interval (95%); CI, 0.20 to 0.41; P < 0.001]. 
There was also a 0.18 increase in the mean DBI, from 
0.21  to  0.38  (pre angioplasty  versus  day  one  post 
angioplasty),  which  was  also  noted  to  be  significant 
[95% CI of 0.11 to 0.24; P < 0.001]. There was also a 
significant  increase  in  TP  from  30.2  to  59.6  (pre 
angioplasty  versus  day  one  post angioplasty),  with  a 
95% CI of 20.2 to 38.2 (P < 0.001). 
Within  the  technically  successful  group,  repeat 
angioplasty was performed on four patients. The reasons 
for the repeat angioplasty included decrease in ABI by 
more than 0.15 (n = 2) and persistent non healing of the 
wound (n = 2) during the follow up period. Of these four 
patients, only one went on to have surgical bypass six 
months after the first angioplasty for persistent rest pain. 
This patient subsequently had an above knee amputation, 
as  the  rest  pain  was  still  not  resolved.  Among  the 
technical  failures  (n = 4),  two  went  on  to  receive 
amputations (both below knee amputations), one went on 
to have a successful bypass operation, and one died of an 
unrelated cause three months later (necrotising fasciitis), 
and had both the lower limbs intact at the time of death.  
Within the technically successful  group, two  went 
on  subsequently  for  successful  bypass  surgeries,  nine 
went on for amputations; five of which were above knee 
amputations, two were below knee amputations and two 
were  forefoot  amputations.There  were  no  instances  of 
significant  distal  embolisation,  arterial  perforations  or 
procedure related  deaths  (30 day  post procedural 
mortality).  All  intimal  dissections  encountered  were 
successfully  treated  with  prolonged  balloon  inflations, 
with no case needing bail out stenting.  
PTA related  complications  that  were  encountered 
included one case of early arterial thrombosis (requiring 
an  above knee  amputation  after  failed  thrombolysis), 
three  cases  of  groin  haematomas  (resolved  with 
conservative treatment) and one case of pseudoaneurysm 
(treated with ultrasound guided compression). 
Limb salvage rates were 93% at one month, 87% at 
three months, 82% at six months, 78% at one year, 69% 
at two years and 66% at three years (Figure 4). Minor 
amputations up to the level of Syme amputation were not 
considered limb loss. Within the study period, there were 
six deaths from unrelated causes (sepsis, pneumonia and 
necrotising fasciitis of the elbow). More importantly, all 
six  patients  had  intact  limbs  at  the  time  of  the  death. 
Kaplan Meir analysis of both the limb salvage rate, as 
well as a combined salvage and survival rate is illustrated 
(Figure 5). Clinically, of the 22 patients who presented 
with rest pain, total abolishment of the symptoms was 
achieved in 20 patients (91%). 17 patients presented with 
pre existing gangrene, for which healing was seen in 11 
patients (66%). Within the technically successful group, 
four  patients  went  on  to  have  minor  amputation  (ray 
amputation)  for  pre existing  gangrene.  Clinical 
improvement  in  the  patients  who  presented  with  non 
healing ulcers (partial or complete healing) and cellulitis 
was  obtained.  More  importantly,  all  healed  ulcers 
remained healed throughout the study period. Tan et al. Biomed Imaging Interv J 2010; 6(4):e33    5 
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Figure 5 Kaplan Meier curve showing the relationship of limb loss and death over time. 
 
Figure 4 3 year limb salvage rate: Change in limb salvage rates 
against time (months) 
DISCUSSION 
Almost all the diabetic patients seen in the authors’ 
centre have extensive infra and supra popliteal disease. 
There has been another study described in the literature 
[2],  which  demonstrates  that  vasculopathy,  namely 
stenosis,  tortuosity,  mural  irregularity  and  calcification 
of  the  arterial  walls,  is  more  frequent  in  patients  with 
diabetes than those without. However, these were often 
non occlusive lesions, particularly calcification along the 
arterial walls. Most of the patients in that study also had 
disease  involving  both  the  femoral  and  infrapopliteal 
vessels.  They  found  that  patients  with  diabetes  had 
arterial  occlusions  less  frequently  than  non diabetic 
patients. They concluded that more attention should be 
paid to morphologic lesions of arteriosclerosis other than 
occlusions  or  stenosis,  and  also  concluded  that  more 
studies were needed to study this topic. Neubauer et al. 
[3] also concluded that large vessels of the muscular type, 
progressive  and  uniform  narrowing,  increased  intima 
roughness  or  rugosity,  and  linear  media  calcification 
were  related  to  type  1  diabetes.  Another  study  by 
Graziani et al. [4] also showed that vascular disease in 
diabetic patients tends to involve the distal calf vessels.  
Hence,  lower  limb  peripheral  vascular  disease  is 
more common in diabetics, with extensive involvement 
of  the  entire  lower  limb.  However,  whether  they  are 
clinically significant is subject to further research.  
The  ethnic  distribution  of  this  study  was  76% 
Chinese,  10%  Malays  and  14%  Indians.  The  ethnic 
distribution in Singapore is 77% Chinese, 14% Malays 
and  7%  Indians.  Hence  there  was  a  disproportionately 
higher  percentage  of  Indians  in  the  study.  It  is  also 
important  to  note  that  the  Indians  in  this  study  were 
predominantly Asian Indians. Studies have demonstrated 
that one important factor contributing to increased type 2 
diabetes  among  Asian  Indians  is  excessive  insulin 
resistance  compared  to  Caucasians  [5].  These  studies 
have  commented  that  the  difference  in  the  degree  of 
insulin  resistance  may  be  explained  by  either 
environmental  or  genetic  factors  or  a  combination  of 
both.  Another  study  has  postulated  that  Asian  Indians 
often have increased visceral fat related to dyslipidaemia, 
and hence, increased frequency of insulin resistance, and 
this may account for the prevalence of diabetes mellitus 
and cardiovascular disease in Asian Indians [6]. 
The reported success rate for endovascular treatment 
of  CLI  is  around  92%  to  96%,  with  a  one year  limb 
salvage rate of 68.6% to 90% [7–11]. This study, which 
is only confined to diabetic patients, shows a one year Tan et al. Biomed Imaging Interv J 2010; 6(4):e33    6 
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limb salvage rate of 78%, which is comparable to those 
other studies. The published three year limb salvage rate 
of PTA is around 77% to 94% [12–14]. The three year 
limb salvage rate of this study is 66%, which makes it 
lower than the other studies. This could be attributed to 
the  fact that this study involved a diabetic population, 
whereas  most  of  the  other  studies  involved  a  general 
population. It has been estimated that 40% to 45% of all 
amputees are diabetic [15], and a diabetic patient with 
CLI is more likely to require an amputation compared to 
a non diabetic [16]. 
DM  affects  CLI  in  many  ways.  Premature  and 
advanced  atherosclerosis,  together  with  peripheral 
neuropathy,  impaired  cellular  immunity  and  impaired 
wound  healing  make  CLI  a  complex  problem  among 
diabetic patients. An aggressive approach must be taken 
to  achieve  optical  glycaemic  control.  Hence,  in  this 
LEAP  program,  all  the  patients  received  review  and 
assessment  by  an  endocrinologist.  Even  under  these 
circumstances, preferential involvement of the distal calf 
vessels,  which  tends  to  be  more  severe,  can  cause 
technical problems during PTA, explaining the relatively 
lower  three year  limb  salvage  rate  compared  to  other 
studies. 
Surgical  bypass,  as  well  as  endovascular  re 
vascularisation,  are  currently  accepted  as  methods  of 
treatment for CLI [13, 17]. Surgical re vascularisation, in 
the  form  of  arterial  bypass,  has  traditionally  been  the 
main  treatment  for  CLI  with  a  well documented  long 
term patency and limb salvage rate [18]. In most surgical 
series, the three year bypass rates of calf arteries ranged 
from 40% for prosthetic bypasses to 85% for saphenous 
bypasses  [7–9,  19,  20].  However,  there  are  limiting 
factors,  such  as  availability  of  long  vein graft  and  the 
presence  of  infection  near  the  site  of  planned  distal 
anastomosis, that make surgery challenging. Moreover, 
the added anaesthetic risk to patients in surgical bypass 
makes PTA an attractive alternative. A recent study by 
Fowkes  et  al.  [21]  described  that  the  mortality  and 
amputation  rates  did  not  differ  significantly  between 
bypass  and  PTA,  though  primary  patency  was 
significantly higher in the bypass group after 12 months, 
but not after four years. Moreover, in the patients with 
lower  CLI,  surgery  was  associated  with  increased 
surgical complications. The study concluded that there 
was  limited  evidence  to  recommend  bypass  surgery 
compared  with  other  treatments,  and  that  further  large 
trials were needed. 
During this study period, there were six deaths, but a 
significant finding is that these deaths were not related to 
CLI. Many of the patients had multiple co morbidities, in 
addition to diabetes. They all died from sepsis secondary 
to other causes, and not from lower limb infection, which 
may  be  due  to  the  immunocompromised  state  of  the 
diabetics.  It  is  known  that  in  diabetic  patients,  co 
existing cardiovascular morbidity and mortality, as well 
as  renal  impairment,  pose  an  even  greater  risk  to 
mortality than CLI.  
The  life  expectancy  of  diabetics  is  often  limited. 
Hence, although the long term patency of angioplasty is 
not as good compared to arterial bypass surgery, if limb 
salvage is the ultimate goal, PTA would be an attractive 
option for these patients. Notably, the clinical results and 
limb salvage after PTA are known to be higher than the 
haemodynamic patency rate and it has been repeatedly 
shown that healed ischaemic lesions do not recur even 
with restenosis of the dilated vessels. In this study period, 
all  the  patients  who  presented  with  non healing  ulcers 
showed  documented  healing  of  the  ulcers  after  PTA. 
Therefore,  less  blood  flow  is  needed  to  keep  tissues 
healed than to achieve healing. Surgical bypass patency, 
on the other hand, always exceeds the limb salvage rate 
[22].  In  addition,  most  of  the  patients  also  showed 
improvement  in  the  presenting  symptoms  of  pain  or 
gangrene. 
Hence, in diabetic patients where life expectancy is 
limited  and  the  aim  is  to  preserve  limb  function, 
angioplasty would be a very attractive option. There have 
been several studies which demonstrate the attractiveness 
of  PTA.  A  retrospective  study  by  Kudo  et  al.  [13] 
showed  that  angioplasty  can  replace  open  surgery 
without compromising the outcome. They concluded that 
angioplasty is not only safe and feasible, but is also an 
effective procedure and is the procedure of choice for the 
primary  and  secondary  treatment  of  CLI.  The  Bypass 
versus  Angioplasty  in  Severe  Ischaemia  of  the  Leg 
(BASIL) multicentre trial [19] also showed further that a 
bypass surgery first  and  a  balloon angioplasty first 
strategy in suitable candidates with infra inguinal disease 
are associated with broadly similar outcomes in terms of 
amputation free  survival,  and  in  the  short  term. 
Furthermore,  the  perimortality  rate  of  PTA  compares 
favourably at around 1% – 3% [19, 20] to 1.8% – 6% for 
distal bypass surgery [7, 20]. 
Limitations  
Limitations  in  this  study  include  potential 
confounders such as adherence to diabetic regimes and 
risk  factor  modification  which have been shown to be 
equally important in altering the outcome in  CLI. The 
lack of anatomical evidence (e.g. Doppler) for long term 
vascular patency is also one limitation. However, if the 
patient did not show any recurrence of initial symptoms, 
it  was  taken  that  there  was  probably  no  need  for 
anatomical evidence. Lastly, the follow up time frame of 
three years may be relatively short, and further follow up 
may  be  necessary  to  evaluate  the  long term  outcome. 
However, this study still demonstrated that PTA is useful 
for patients over the three year outcome.  
CONCLUSION 
Peripheral vascular disease in diabetics is severe and 
extensive. The most common pattern involves both the 
femoral and infrapopliteal vessels, with a high incidence 
of infrapopliteal disease that needs to be treated. First 
year  limb  salvage  rates  are  similar  to  those  of  other 
studies,  but  the  three year  limb  salvage  rate  is  less, 
probably  due  to  more  extensive  peripheral  vascular Tan et al. Biomed Imaging Interv J 2010; 6(4):e33    7 
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disease.  Diabetics  with  CLI  have  a  limited  life 
expectancy and often die from a non limb related cause. 
Hence,  PTA  is  a  good  and  viable  option  for  these 
patients, where additional anaesthetic and surgical risks 
may  not  make  bypass  the  best  option.  The  three year 
limb salvage rate in this study is 66%, which makes PTA 
an attractive option for the treatment of CLI in diabetic 
patients. 
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